Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone for Hazardous Drinking in HIV-Infected Women
NCT01625091Phase 3Completed
- Sponsor
- University of Florida
- Start
- Dec 2012
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in alcohol use disorder (AUD) comparing Naltrexone Arm with Placebo Arm (2 arms). Primary endpoint: Number of Participants Who Quit Hazardous Drinking at 4 months. Started Dec 2012; status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT01625091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01625091.